The same effect was observed when TSPO ligands were used to treat human neuroblastoma SH-SY5Y cells (Hallé et al., 2017; Lejri et al., 2019), human microglia cell lines (Da Pozzo et al., 2016; Lin et al., 2022), human astrocyte cell line (Lin et al., 2022), human glioblastoma cells (Lin et al., 2022), and rat glioma C6 cells (Da Pozzo et al., 2016; Santoro et al., 2016). This evidence concerns the gene TSPO and neuroblastoma.